LITE
Lumentum Holdings Inc.
AI Optics / EML Laser Chips
$1,053
Mkt Cap ~$75–82B 1
52W: $69.26 – $1,073.33
Next earnings: ~18 Aug 2026 (Q4 FY26) 2
👁 WATCH
Entry zone: $780 – $870
The market is pricing LITE as a transceiver-volume commodity beneficiary; the structural value is the indium-phosphide EML laser-chip oligopoly (LITE + Coherent), where NVIDIA's $2B strategic preferred investment is a supply-security rent signal — but the consensus has already arrived, and the stock has priced in three years of perfection in nine weeks.
TTM P/E
~168×
Fwd P/E
80–95×
⚠ Derived — see notes
Rev YoY
+90.1%
Q3 FY26 3
Non-GAAP GM
47.9%
Q3 FY26 3
Non-GAAP OM
32.2%
Q3 FY26 3
Q4 Rev Guide
$960M–$1.01B
EPS guide $2.85–$3.05 3
Thesis Durability
A
LITE's structural moat is the indium-phosphide EML laser chip — ~50–60% share of high-end EML supply, the only vendor shipping 200G-per-lane EMLs at hyperscale volume.4 Every AI-optics architecture (pluggable 800G/1.6T and CPO) needs these lasers. NVIDIA's $2B Series A Preferred (non-exclusive, but a multi-billion supply commitment) is NVIDIA allocating capacity across the only two suppliers with yield.5
TAM: optical transceiver market $15.4B (2026) → $29.3B (2031) at 13.7% CAGR.6 Datacom optics alone exceeded $16B in 2025 and grew >60%.7 CPO adds a second growth vector: LightCounting projects EML/PIC laser TAM $2.4B (2023) → $5.9B (2029).8
Bear stress-test: Innolight and Eoptolink dominate ~60% of NVIDIA 800G module supply4 and are ~12–18 months behind LITE on vertical EML integration. If they close the gap by 2027, LITE's pricing power compresses. CPO architecture also requires fewer-but-better lasers vs pluggables — TAM-per-unit count may shrink even as ASP holds.
FQ3 surprise — pump lasers more constrained than EMLs: This was not on consensus radar. Pump lasers for DCI (data centre interconnect) are now effectively sold out — management characterised this as "unanticipated" and confirmed the supply-demand imbalance across EMLs is now >30% (widened from the prior quarter's 25–30%). Pump laser shipments +80% YoY; narrow linewidth lasers +120% YoY (ninth consecutive quarter of growth). LITE is now in discussions with major customers for prepayment, take-or-pay, and pricing increases to fund the required capex expansion — these are margin-accretive financing structures, not a sign of weakness.16
A third growth vector beyond CPO: optical circuit switches (OCS), $400M H2 2026 target confirmed (ramp to >$1B in calendar 2027). Note: OCS supply itself is now experiencing "considerable tightness" — tied partly to Google TPU v8 content per switch increasing vs TPU v7 — which could create some timing lumpiness in the ramp.16
TAM: optical transceiver market $15.4B (2026) → $29.3B (2031) at 13.7% CAGR.6 Datacom optics alone exceeded $16B in 2025 and grew >60%.7 CPO adds a second growth vector: LightCounting projects EML/PIC laser TAM $2.4B (2023) → $5.9B (2029).8
Bear stress-test: Innolight and Eoptolink dominate ~60% of NVIDIA 800G module supply4 and are ~12–18 months behind LITE on vertical EML integration. If they close the gap by 2027, LITE's pricing power compresses. CPO architecture also requires fewer-but-better lasers vs pluggables — TAM-per-unit count may shrink even as ASP holds.
FQ3 surprise — pump lasers more constrained than EMLs: This was not on consensus radar. Pump lasers for DCI (data centre interconnect) are now effectively sold out — management characterised this as "unanticipated" and confirmed the supply-demand imbalance across EMLs is now >30% (widened from the prior quarter's 25–30%). Pump laser shipments +80% YoY; narrow linewidth lasers +120% YoY (ninth consecutive quarter of growth). LITE is now in discussions with major customers for prepayment, take-or-pay, and pricing increases to fund the required capex expansion — these are margin-accretive financing structures, not a sign of weakness.16
A third growth vector beyond CPO: optical circuit switches (OCS), $400M H2 2026 target confirmed (ramp to >$1B in calendar 2027). Note: OCS supply itself is now experiencing "considerable tightness" — tied partly to Google TPU v8 content per switch increasing vs TPU v7 — which could create some timing lumpiness in the ramp.16
High-conviction structural moat. EML oligopoly is real; variant perception has been absorbed by consensus but the moat itself remains intact at the laser-chip layer.
Business Quality
A–
Quarterly progression (FY26): non-GAAP GM from 35.2% (Q3 FY25) → 42.5% (Q2 FY26) → 47.9% (Q3 FY26); operating margin 10.8% → 25.2% → 32.2%; EPS $0.57 → $1.67 → $2.37.3 Four straight consensus beats.9
NVIDIA's $2B cash injection eliminated the legacy net-debt position ($1.67B pre-deal → ~flat net): cash + ST investments now $3.17B vs long-term debt $43.2M.3 This is the deal's most under-appreciated benefit.
Estimate revisions are sharply UP: 10 sell-side PTs doubled in a single cycle (Jefferies $900 → $1,200; Rosenblatt $900 → $1,300; JPMorgan $940 → $1,130).10 Mean PT ~$1,064 = now essentially at spot — analyst cushion consumed.
Insider Form 4 (90-day flag): CFO Ali Wajid sold 5,302 shares at ~$678–$699 (27 Feb 2026, ~$3.7M).11 EVP Vincent Retort sold 45,026 shares (12 Feb) + 3,441 (17 Feb).12 President Wupen Yuen sold 3,157 shares (17 Feb).11 All are 10b5-1 pre-scheduled plans (adopted Nov 2025) — not opportunistic, but zero open-market buys in the last year is a tonal flag. No single sale >$50M.
Short interest: 11.5–12.4% of float13, down 22.3% MoM — shorts covering, removing prior bullish squeeze dynamic.
CW laser insourcing — one quarter ahead of schedule: Management confirmed CW laser insourcing began in Q3 FY26, one quarter earlier than guided. By Q4 FY26, insourced CW lasers are expected to account for ~20% of transceiver modules; this percentage scales as the 1.6T ramp accelerates. Insourcing directly augments gross margin (eliminating third-party laser cost), making the already-strong GM trajectory more durable into the cycle rather than peaking at current levels.16
$2B/quarter revenue target + Greensboro fab: At March OFC, management confirmed a $2B/quarter revenue target to be achieved within 18–24 months (consensus puts this at December 2027). To support this, LITE acquired the Greensboro, NC fab from Qorvo — its fifth InP fab — adding >$5B of annual run-rate CPO capacity once fully ramped. First material contributions from Greensboro are not expected until 2028, meaning the capacity is being built well ahead of demand, reducing the risk of a supply bottleneck capping the ramp.16
NVIDIA's $2B cash injection eliminated the legacy net-debt position ($1.67B pre-deal → ~flat net): cash + ST investments now $3.17B vs long-term debt $43.2M.3 This is the deal's most under-appreciated benefit.
Estimate revisions are sharply UP: 10 sell-side PTs doubled in a single cycle (Jefferies $900 → $1,200; Rosenblatt $900 → $1,300; JPMorgan $940 → $1,130).10 Mean PT ~$1,064 = now essentially at spot — analyst cushion consumed.
Insider Form 4 (90-day flag): CFO Ali Wajid sold 5,302 shares at ~$678–$699 (27 Feb 2026, ~$3.7M).11 EVP Vincent Retort sold 45,026 shares (12 Feb) + 3,441 (17 Feb).12 President Wupen Yuen sold 3,157 shares (17 Feb).11 All are 10b5-1 pre-scheduled plans (adopted Nov 2025) — not opportunistic, but zero open-market buys in the last year is a tonal flag. No single sale >$50M.
Short interest: 11.5–12.4% of float13, down 22.3% MoM — shorts covering, removing prior bullish squeeze dynamic.
CW laser insourcing — one quarter ahead of schedule: Management confirmed CW laser insourcing began in Q3 FY26, one quarter earlier than guided. By Q4 FY26, insourced CW lasers are expected to account for ~20% of transceiver modules; this percentage scales as the 1.6T ramp accelerates. Insourcing directly augments gross margin (eliminating third-party laser cost), making the already-strong GM trajectory more durable into the cycle rather than peaking at current levels.16
$2B/quarter revenue target + Greensboro fab: At March OFC, management confirmed a $2B/quarter revenue target to be achieved within 18–24 months (consensus puts this at December 2027). To support this, LITE acquired the Greensboro, NC fab from Qorvo — its fifth InP fab — adding >$5B of annual run-rate CPO capacity once fully ramped. First material contributions from Greensboro are not expected until 2028, meaning the capacity is being built well ahead of demand, reducing the risk of a supply bottleneck capping the ramp.16
Pristine execution trajectory; balance sheet transformed. CW insourcing ahead of schedule adds margin durability; $2B target has a credible infrastructure underpinning. Insider selling is plan-based but unanimous direction is notable.
Entry Price Discipline
D
Current price: $1,053 (12 May 2026)1 — 21–35% above entry zone of $780–$870. Stock is 1.2% below all-time high ($1,073.33).2
TTM P/E ~168×.1 Fwd P/E ~80–95× (⚠ derived from Q4 guide × 4 + ramp; no third-party consensus NTM EPS directly available).⚠ Vs optics sector median ~25–30× fwd P/E, LITE trades at 2.5–3× sector median. Vs COHR (43–51× fwd P/E), LITE is ~1.7–2× COHR's multiple for identical NVIDIA economics.
Q3 beat: revenue $808.4M vs $802.9M consensus (+0.37% beat — thin).9 Non-GAAP EPS $2.37 vs $2.27 consensus (+4.4% beat).9
Nasdaq-100 inclusion 18 May 2026: mechanical buying pre-event already in price; inclusion = exhaustion of index-flow tailwind.
Sell-side mean PT ~$1,064 — essentially at spot — means the forward-return profile from sell-side models is near-zero. To make money from here requires either multiple expansion (betting on further euphoria) or sustained 30%+ revenue CAGR for 5+ years.
TTM P/E ~168×.1 Fwd P/E ~80–95× (⚠ derived from Q4 guide × 4 + ramp; no third-party consensus NTM EPS directly available).⚠ Vs optics sector median ~25–30× fwd P/E, LITE trades at 2.5–3× sector median. Vs COHR (43–51× fwd P/E), LITE is ~1.7–2× COHR's multiple for identical NVIDIA economics.
Q3 beat: revenue $808.4M vs $802.9M consensus (+0.37% beat — thin).9 Non-GAAP EPS $2.37 vs $2.27 consensus (+4.4% beat).9
Nasdaq-100 inclusion 18 May 2026: mechanical buying pre-event already in price; inclusion = exhaustion of index-flow tailwind.
Sell-side mean PT ~$1,064 — essentially at spot — means the forward-return profile from sell-side models is near-zero. To make money from here requires either multiple expansion (betting on further euphoria) or sustained 30%+ revenue CAGR for 5+ years.
Priced to perfection — do not chase above $870. Three years of growth compressed into nine weeks; no margin of safety at any plausible DCF scenario.
Verdict — Watch / Add on Pullback
Lumentum is operationally the highest-quality AI-optics business in the public market: EML laser-chip oligopoly, 47.9% non-GAAP gross margin, 32.2% operating margin, balance sheet transformed by NVIDIA's $2B Series A preferred, and a Q4 guide of $960M–$1.01B that puts it on track for $3.8–4.0B in FY26 revenue. The thesis is sound. The problem is that the market now knows all of this — consensus PTs have doubled, the Nasdaq-100 inclusion is days away, and the stock is 1.2% below ATH after a ~15× move from its 52-week low. Both bull and bear DCF scenarios produce fair values well below $1,053 ($227 bull / $105 bear). The asymmetric setup that existed at $350–550 no longer exists. Wait for one of three re-entry triggers: (1) Nasdaq-100 inclusion air-pocket post-18 May; (2) market-wide AI-optics rotation drawdown of 15–20%; (3) Innolight-scare news creating a temporary dislocation. None of these require the thesis to break — just for the momentum to pause.
Head-to-head ruling: COHR remains the better-priced optics add today (47–51× fwd P/E vs LITE 80–95×) for ~80% of the same thesis. If you can only own one optics name, COHR. LITE and COHR are ~70% thesis-redundant — owning both is double-counting the NVIDIA-photonics trade.
Head-to-head ruling: COHR remains the better-priced optics add today (47–51× fwd P/E vs LITE 80–95×) for ~80% of the same thesis. If you can only own one optics name, COHR. LITE and COHR are ~70% thesis-redundant — owning both is double-counting the NVIDIA-photonics trade.
New position: 0% now. Add 3–5% of portfolio on entry into $780–$870. Do not add above $920. If COHR is already held, do not initiate LITE — redundant exposure. 20% single-stock cap applies.
Head-to-head: LITE vs COHR
▾
Both received identical NVIDIA $2B Series A Preferred investments (2 Mar 2026). COHR and LITE are the only two Western companies at scale in EML laser chips and high-speed transceivers for AI data centres.
| Metric | LITE | COHR | Edge |
|---|---|---|---|
| Price (12 May) | $1,053 | ~$335 | — |
| Market cap | ~$75–82B | ~$74B | Comparable |
| Latest qtr revenue | $808.4M | $1,805.6M | COHR (2.2× scale) |
| Revenue YoY | +90.1% | +20.5% (+27% pro forma) | LITE |
| Non-GAAP gross margin | 47.9% | 39.6% | LITE (+830 bps) |
| Non-GAAP op margin | 32.2% | 20.3% | LITE (+1,190 bps) |
| Forward P/E (NTM) | ~80–95× ⚠ | ~47–51× | COHR (half the multiple) |
| EML laser chip share | ~50–60%, only 200G-per-lane at scale | InP capacity doubled ahead of sched. | LITE narrowly |
| Backlog visibility | Multi-billion NVIDIA commitment, "supply tight to 2027+" | Customer orders into calendar 2028 | COHR (more dated) |
| NVIDIA deal terms | $2B / Series A Conv. Pref. @ $695.31 — non-exclusive | $2B — same structure | Identical |
| Balance sheet | Cash $3.17B; debt ~flat net | D/E 0.31, current ratio 3.05 | COHR slightly cleaner |
| Short interest | ~11.5–12.4% of float | ~3.3% of float | COHR (less crowded) |
| Index inclusion | Nasdaq-100 18 May 2026 | S&P 500 (already in) | — |
| Thesis redundancy | ~70% overlap — pick one, not both | ||
Single-name ruling: COHR is the better-priced optics add today. LITE wins only if you specifically want the pure-play EML chip moat and are willing to pay a 1.7–2× multiple premium over COHR for it.
Opportunity-cost check
▾
vs CSPX
CSPX will own LITE via passive Nasdaq-100 weighting after 18 May — the argument for active concentration only holds if LITE can outperform the index by >15% over 2 years, which at current valuation requires compounding further multiple expansion on top of already-priced-in fundamentals. At entry zone $780–$870, this hurdle clears; at $1,053, it does not.
vs current holdings
COHR is already a Strong Add on the watchlist and covers ~80% of the same thesis (AI optics, NVIDIA CPO, EML supply chain). Adding LITE on top of COHR concentrates optics exposure without meaningful diversification. LITE stacks the same factor as COHR + NVDA (both held in MAGS). The correct displacement is COHR first; LITE only if COHR is not held.
Thesis-breakers
▾
Three specific, observable data points that — if seen — force a sell or downgrade to Do Not Add.
- 01 EML chip competition: Innolight or any Chinese vendor publicly qualifies or ships 200G-per-lane EMLs at NVIDIA hyperscale volume by end of Q2 FY27 (December 2026) — structural moat breached; expect 25%+ multiple compression regardless of revenue.
- 02 Revenue deceleration: Q4 FY26 revenue (August 2026 print) below $960M (low end of guide) or Q1 FY27 guide below $1.05B — AI-ramp slowdown confirmed; at 80–95× fwd P/E, any guide-miss triggers a 20–30% drawdown minimum.
- 03 NVIDIA strategic shift: NVIDIA's next 10-K (April 2027) discloses Coherent purchase commitment materially larger than Lumentum's, or NVIDIA's CPO architecture transitions to non-EML laser sourcing by Q2 CY2027 — the "preferred supply partner" narrative inverts.
Key risks
▾
- 01 Chinese vertical integration: Innolight and Eoptolink already dominate ~60% of NVIDIA's 800G module supply4 and are closing the EML yield gap. If they ship 200G EMLs at scale by 2027, LITE's pricing power compresses — estimated 20–30% ASP erosion over 2 years is a reasonable bear scenario.
- 02 CPO laser-count reduction: NVIDIA's Quantum-X CPO switch uses fewer but higher-quality lasers vs pluggables (3.5× power efficiency claimed). If CPO ramp in 2H26 reduces total laser units per rack, LITE's unit TAM shrinks even if CPO-specific ASPs hold. Revenue trajectory vs current guide could disappoint without a direct "miss."
- 03 NVIDIA concentration and pricing influence: NVIDIA holds a ~3% economic-equity stake (if-converted) and is the dominant strategic customer. As both a major buyer and a shareholder, NVIDIA can exert pressure on LITE's pricing, supply allocation, and manufacturing roadmap — an inherent conflict of interest that doesn't exist for COHR to the same degree.
- 04 Convertible debt maturity cliff: Current portion of long-term debt $3.24B3 — existing convertible notes rolling/maturing need to be refinanced or converted. If capital markets conditions deteriorate, this becomes a liquidity event despite the NVIDIA cash cushion of $3.17B. Net exposure is roughly neutral now, but the gross positions are large.
- 05 Valuation cliff at multiple compression: At 80–95× fwd P/E, a re-rating to 50× fwd P/E (COHR's current multiple) produces a ~45–50% drawdown on LITE with zero change in fundamentals. Any macro derating event, AI-capex concern, or index rebalancing creates an outsized price impact relative to business performance.
DCF scenarios
▾
Discount rate: 14–15% — LITE is high-growth, recently profitable (FY26 first sustained GAAP-adjacent profitability), with a concentrated NVIDIA customer dependency and ~$3.2B in convertible debt. Profile sits between "high-growth profitable" (13%) and "speculative/concentration risk" (15%). Base rate 14% used.
FCF base year: FY26E ~$520–$580M (estimated from ~$3.8B revenue at ~15% FCF margin — the non-GAAP operating leverage implies 15–18% FCF margin is achievable before capex intensification for the new U.S. fab). Shares outstanding: ~100M fully diluted (incl. preferred).
5Y rev CAGR
25%
FCF margin Y5
25%
Fair value / share
~$227
vs current ($1,053)
−78%
Bull: NVIDIA purchase commitment ramps fully, CPO is additive rather than substitutive for EML units, Chinese competitors fail to close 200G EML yield gap by 2027. FY26 FCF base ~$550M; 5Y path: $688M → $860M → $1,075M → $1,344M → $1,680M (25% CAGR). Terminal value at 5% terminal growth: PV of explicit FCFs ~$3.9B + PV of terminal ~$13.5B = EV ~$17.4B; equity value per share ~$174. Adding a strategic/scarcity premium to ~$227. Current price ($1,053) is 4.6× the bull-case fair value.
5Y rev CAGR
17.5%
FCF margin Y5
18%
Fair value / share
~$105
vs current ($1,053)
−90%
Bear: 30% deceleration immediately as Innolight closes EML gap; FCF margin stuck at 18% from pricing competition. FY26 FCF base ~$500M; 5Y path: $500M → $588M → $691M → $812M → $955M. Terminal value: EV ~$10.5B; per share ~$105. Current price ($1,053) is 10× the bear-case fair value.
Position: Current price is far above both scenarios — 4.6× the bull case fair value. LITE is uninvestable on conventional DCF at $1,053. The stock prices in a multi-decade S-curve compounding thesis, not a 5-year cash flow model. Wait for price to compress into at least the $780–$870 zone where entry discipline is restored.
Catalyst timeline
▾
-
2026-05-18Nasdaq-100 inclusion effective. Mechanical passive buying completes. Risk: "sell the news" air pocket post-inclusion is the most likely near-term re-entry opportunity. Watch for 5–10% drawdown in the 2 weeks post-inclusion.
-
2026-08Q4 FY26 earnings (~18 Aug). Key tests: (1) does revenue beat the $1.01B top of guide? (2) Initial FY27 commentary — does management dimension the NVIDIA CPO purchase commitment? (3) Any U.S. fab build update and capex implications. A beat-and-raise here validates the entry zone and could trigger upgrade to Add (pullback).
-
2026-H2NVIDIA Spectrum-X Photonics CPO commercial launch. First full-scale CPO deployment in a hyperscaler cluster. If LITE is disclosed as the primary laser supplier, it is a structural signal justifying a higher base-case multiple. If Coherent is named exclusively, thesis re-evaluates.
-
2026-H2 / 2027-Q1Innolight/Eoptolink 1.6T qualification milestones. The single most important competitive datapoint. If Chinese vendors complete NVIDIA 1.6T qualification before CY2027, LITE's EML moat narrowing begins earlier than modelled.
-
2027OCS backlog conversion. Lumentum's optical circuit switch backlog stood at $400M against ~$10M in quarterly revenue as of Q2 FY2026.15 Revenue ramp from this contracted pipeline is not in consensus models. First material OCS quarter (>$50M) would be an incremental upside catalyst not currently priced into sell-side estimates.
Named analyst commentary
▾
"Lumentum has a differentiated technology that has caught the attention of AI heavyweights such as Nvidia, and the company's Electro-absorption modulated lasers (EMLs) are a critical component with Nvidia's Blackwell generation … reaching its $600 million quarterly revenue target two quarters ahead of schedule, primarily reflecting accelerating AI-driven demand."
— Beth Kindig, Substack, 2026
"Lumentum has been on our radar for more than one year … We've been closely monitoring Lumentum and waiting patiently for their EML lasers for 200G to ship, enabling 800G and 1.6T bandwidths."
— Beth Kindig, Substack, 9 Jan 2026
"Nvidia is securing its supply chain as it ramps its co-packaged optics (CPO) roadmap and writing big checks to do so … The report is built on the same investment discipline that identified massive winners like Bloom Energy and Lumentum early in their AI cycle."
— Beth Kindig, Substack (post-NVIDIA deal), March 2026
"Considering the scope of this raise for Q3, it's likely that estimates for Q4, which currently are pegged at just $770.4 million, are revised much higher in the coming days/weeks. As a result, it's likely that consensus estimates for FY26, currently at $2.64 billion, move ~8–10% higher."
— Beth Kindig, IO Fund Premium (Q2 FY2026 earnings commentary), Apr 2026 ⚠ Q4 guide subsequently came in at $960M–$1.01B — 28% above the $770.4M consensus she flagged. FY26 estimates revised up to ~$2.92B (+10.6%).15
Dylan Patel / SemiAnalysis — No coverage from tracked analysts located on LITE specifically.
Serenity (@aleabitoreddit) — No coverage from tracked analysts located on LITE specifically.
Sources
1 Investing.com / Robinhood — LITE price and market cap, accessed 13 May 2026 Market cap conflict: basic vs fully-diluted
2 TradingView NASDAQ:LITE — 52W range, earnings date estimate, accessed 13 May 2026
3 SEC EDGAR — Lumentum Holdings Inc. 8-K (Q3 FY26 results), filed 5 May 2026 (lite_ex991xq3fy26.htm)
4 MLQ.ai optical networking research; ip-fiber.com (Baudcom) — Innolight/Eoptolink 800G market share
5 SEC EDGAR — Lumentum Holdings Inc. 8-K (NVIDIA $2B investment), filed 2 Mar 2026; StockTitan summary
6 Mordor Intelligence — Optical Transceiver Market report, accessed May 2026
7 Cignal AI — "800GbE Optics Shipments to Grow 60% in 2025", May 2025
8 LightCounting / Siemens blog — CPO laser/PIC TAM projections, accessed via Siemens semiconductor packaging blog, February 2026
9 Yahoo Finance / Investing.com — LITE Q3 FY26 consensus beat vs estimates, accessed May 2026
10 TipRanks / Tickernerd — LITE analyst PT revisions post-Q3 FY26, accessed May 2026
11 StockTitan — LITE Form 4 filings (CFO Wajid, President Yuen), February 2026
12 GuruFocus — Vincent Retort Form 4 (45,026 shares), February 2026
13 StockTitan / StockAnalysis — LITE short interest, accessed May 2026 45-day 13F lag
14 Beth Kindig — Substack, 9 Jan 2026; subsequent posts 2026
15 Beth Kindig / IO Fund Premium — "The IO Fund's Top 15 Stocks for Q2 2026", Q2 2026 (exact publication date not disclosed); paywalled
16 IO Fund (Beth Kindig) — "Lumentum FQ3: Firing on All Cylinders Despite Stiff Supply Constraints Across EMLs & Pump Lasers", May 2026 (premium)
⚠ = Forward P/E (~80–95×) is derived from Q4 guide annualised + ramp; no third-party consensus NTM EPS value was independently triangulated within this research cycle. RSI reported as ~84 (post-NVIDIA-deal spike) — current value not refreshed. Dataroma superinvestor positioning post-NVIDIA deal not yet publicly available (Q1 2026 13F window).
1 Investing.com / Robinhood — LITE price and market cap, accessed 13 May 2026 Market cap conflict: basic vs fully-diluted
2 TradingView NASDAQ:LITE — 52W range, earnings date estimate, accessed 13 May 2026
3 SEC EDGAR — Lumentum Holdings Inc. 8-K (Q3 FY26 results), filed 5 May 2026 (lite_ex991xq3fy26.htm)
4 MLQ.ai optical networking research; ip-fiber.com (Baudcom) — Innolight/Eoptolink 800G market share
5 SEC EDGAR — Lumentum Holdings Inc. 8-K (NVIDIA $2B investment), filed 2 Mar 2026; StockTitan summary
6 Mordor Intelligence — Optical Transceiver Market report, accessed May 2026
7 Cignal AI — "800GbE Optics Shipments to Grow 60% in 2025", May 2025
8 LightCounting / Siemens blog — CPO laser/PIC TAM projections, accessed via Siemens semiconductor packaging blog, February 2026
9 Yahoo Finance / Investing.com — LITE Q3 FY26 consensus beat vs estimates, accessed May 2026
10 TipRanks / Tickernerd — LITE analyst PT revisions post-Q3 FY26, accessed May 2026
11 StockTitan — LITE Form 4 filings (CFO Wajid, President Yuen), February 2026
12 GuruFocus — Vincent Retort Form 4 (45,026 shares), February 2026
13 StockTitan / StockAnalysis — LITE short interest, accessed May 2026 45-day 13F lag
14 Beth Kindig — Substack, 9 Jan 2026; subsequent posts 2026
15 Beth Kindig / IO Fund Premium — "The IO Fund's Top 15 Stocks for Q2 2026", Q2 2026 (exact publication date not disclosed); paywalled
16 IO Fund (Beth Kindig) — "Lumentum FQ3: Firing on All Cylinders Despite Stiff Supply Constraints Across EMLs & Pump Lasers", May 2026 (premium)
⚠ = Forward P/E (~80–95×) is derived from Q4 guide annualised + ramp; no third-party consensus NTM EPS value was independently triangulated within this research cycle. RSI reported as ~84 (post-NVIDIA-deal spike) — current value not refreshed. Dataroma superinvestor positioning post-NVIDIA deal not yet publicly available (Q1 2026 13F window).